Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.
Also called NCT01442987
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 230 participants
- Registry
-
NCT01442987
-
- Other papers using this trial's data
- Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01442987. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2013-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Irbesartan/Atorvastatin A
- Intervention (Drug)
- Irbesartan
- Intervention (Drug)
- Atorvastatin A
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Irbesartan/Atorvastatin B
- Intervention (Drug)
- Atorvastatin B
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct01442987- Content hash
3674442751f1f1d6a6c31bff209ff6fd30585b3b6d625c015bea1c6033bd1fa0